Moura Andre V. 4
4 · Bellerophon Therapeutics, Inc. · Filed Sep 30, 2019
Insider Transaction Report
Form 4
Moura Andre V.
Director
Transactions
- Award
Stock Option (right to buy)
2019-09-26+46,266→ 104,482 totalExercise: $0.50From: 2020-09-26Exp: 2029-09-26→ Common Stock (46,266 underlying)